Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Pulmonary veno-occlusive disease: Which Medications Are Safest? (29 Drugs Compared)

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

29 medications are used for Pulmonary veno-occlusive disease, with 117 combined adverse event reports. The most reported drugs for Pulmonary veno-occlusive disease are TREPROSTINIL and EPOPROSTENOL.

117
Total Reports
29
Drugs Used

All Medications for Pulmonary veno-occlusive disease Ranked by Safety Reports

Drug Brand Reports Deaths (all) Hosp. (all) Death Rate
TREPROSTINIL TYVASO 22 8,865 35,507 9.7%
EPOPROSTENOL EPOPROSTENOL 20 2,713 8,838 20.4%
AMBRISENTAN AMBRISENTAN 17 10,291 32,910 11.9%
SILDENAFIL Sildenafil 14 4,979 8,623 14.1%
IMATINIB Imatinib 13 13,761 7,264 31.9%
MACITENTAN OPSYNVI 11 9,886 24,183 21.8%
DEFIBROTIDE DEFITELIO 8 1,804 832 48.2%
BOSENTAN Tracleer 5 4,346 8,862 22.2%
SELEXIPAG Selexipag 5 3,778 9,394 20.5%
TADALAFIL Esokalli Testosterone Booster Oral Dissolving Film 5 3,553 8,717 11.6%

View all 29 drugs →

Most Reported Drugs for Pulmonary veno-occlusive disease

#1 most reported
#2 most reported
#3 most reported